article thumbnail

Survey Reveals Almost Half of Canada’s MMJ Patients Reduced Their Alcohol and Opioid Consumption

Veriheal

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

article thumbnail

Marijuana for Nausea: Helping Cancer Patients for Decades

Greencamp

Marijuana for nausea became FDA approved and available for medicinal use in 1985 in the US, and Canada legalized it for these purposes back in 2001. Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. References.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK – BMJ Report: ” Medical cannabis: patients turn to private clinics because of NHS void”

Cannabis Law Report

How will private clinics start seeing patients who request medical cannabis based products when NHS doctors seem unable to? They offer to treat patients for pain, cancer, and gastrointestinal, neurological, and psychiatric conditions. But why are these patients being left to seek treatment from the private sector?

article thumbnail

Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers

Veriheal

annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. The team peered into the findings of numerous articles published between 2001 and 2019. Chronic pain —a condition that affects 50.2 million people in the U.S.

article thumbnail

Doctors to Debate Medical Pot as More Patients Expected to Ask for Prescriptions

Puff Puff Post

VANCOUVER — Doctors with opposing views on whether medical marijuana should be prescribed for various conditions agree on one thing: their profession is ill-prepared to deal with patients asking for a drug that lacks adequate clinical research. “So I think a lot of the claims are false.”

article thumbnail

Answer of the Day for Jul 13, 2022

TheAnswerPage

Canada legalized cannabis for medical use in 2001 and for adult recreational use in 2018 at the federal level. “Since the legalization of recreational cannabis in Canada, prescriptions for opioids, gabapentin, and pregabalin have decreased, especially among patients with public payer insurance plans.” ” Holman, A.,

article thumbnail

UK: Cannabis firm, Cantourage, launches clinic following prescription license allocation

Cannabis Law Report

Cantourage UK is now in receipt of the necessary narcotics licence from the Home Office to handle cannabis-based products for medicinal use, under the Misuse of Drugs Regulations 2001. Our strategy in the UK has been built to improve patient access and care,” Newman concluded. “We

Access 52